Australia's CSL extends losses to hit lowest since 2018

Csl

28/10/2025 23:24

** Shares of Australian biotech giant CSL CSL.AX fall 3.7% to A$171.25; hit lowest since May 2018

** Stock extends losses from its 15.9% slump on Tuesday; on track for fifth straight day of decline

** On Tuesday, CSL cut profit forecast and delayed plans to spin off its vaccine division

** Company blamed an unprecedented fall in U.S. flu immunization rates

** Investors, frustrated with company's tanking share price, rejected executive pay packages for the second year in a row in AGM on Tuesday

** Shares down 39% YTD

 (Reporting by Rishav Chatterjee in Bengaluru)

 ((Rishav.Chatterjee@thomsonreuters.com))